Landlocked developing countries (LLDCs) vs Sweden: Proportion of the target population who received the final dose
Landlocked developing countries (LLDCs)
44.0%
in 2024
Sweden
87.0%
in 2024
Landlocked developing countries (LLDCs) rank
17th
Sweden rank
16th
Proportion of the target population who received the final dose over time
- Landlocked developing countries (LLDCs)
- Sweden
How they compare
Sweden currently reports 87.0% against 44.0% in Landlocked developing countries (LLDCs), a difference of 43.0%.
That makes Sweden's figure about 2.0 times Landlocked developing countries (LLDCs)'s.
Across all 9 years both countries report, Sweden has been ahead every year.
Landlocked developing countries (LLDCs) ranks 17th and Sweden ranks 16th of 34 groups.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.8% | 75.0% | 64.2% | Sweden |
| 2020s | 28.2% | 85.6% | 57.4% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Landlocked developing countries (LLDCs) or Sweden?
- Sweden, at 87.0% against 44.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Landlocked developing countries (LLDCs) and Sweden?
- 43.0%, with Sweden ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Sweden?
- 9 years are reported by both, from 2016 to 2024.
- How do Landlocked developing countries (LLDCs) and Sweden rank globally for proportion of the target population who received the final dose of?
- Landlocked developing countries (LLDCs) ranks 17th and Sweden ranks 16th of 34 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.